Talo, Marasiya .
HRN: 03-91-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/20/2022
11/27/2022
IVTT
500mg
Q8
Pus Cells On Stool With Amoeba
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes